Identifying differential responders and their characteristics in clinical trials: Innovative methods for analyzing longitudinal data

Value in Health

Volumn 16, Issue 1, 2013, Pages 164-176

  Stull, Donald E ^a   Houghton, Katherine ^a  

^a RTI HEALTH SOLUTIONS   (United States)

Author keywords

differential responders; heart failure; heterogeneity; mixture model

Indexed keywords

CREATININE; ENALAPRIL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); CRITERION VARIABLE; DATA ANALYSIS; DEPRESSION; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GROWTH MIXTURE MODELING; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY; NONBIOLOGICAL MODEL; POST HOC ANALYSIS; PRIORITY JOURNAL; TREATMENT RESPONSE; VISUAL SYSTEM EXAMINATION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME;

EID: 84872695666     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.08.2215     Document Type: Article

References (40)

1. S.H. Kaplan, J. Billimek, and D.H. Sorkin Who can respond to treatment? Identifying patient characteristics related to heterogeneity of treatment effects Med Care 48 Suppl 2010 S9 16
2. J.S. Leoutsakos, B.O. Muthén, J.C.S. Breitner, and C.G. Lyketsos Effects of NSAID treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled ADAPT trial Int J Geriatr Psychiatry 27 2012 364 374
3. B. Muthén, and H.C. Brown Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling Stat Med 28 2009 3363 3385
4. B. Muthén, C.H. Brown, and A. Hunter General approaches to analysis of course: applying growth mixture modeling to randomized trials of depression medication P.E. Shrout, Causality and Psychopathology: Finding the Determinants of Disorders and Their Cures 2011 Oxford University Press New York
5. D.E. Stull, I. Wiklund, and R. Gale Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD Contemp Clin Trials 32 2011 818 828
6. R.L. Kravitz, N. Duan, and J. Braslow Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages Milbank Q 82 2004 661 687
7. D.E. Stull Analyzing growth and change: latent variable growth curve modeling with an application to clinical trials Qual Life Res 17 2008 47 59
8. S.A. Hardy, and C. Thiels Using latent growth curve modelling in clinical treatment research: an example comparing guided self-change and cognitive behavioral therapy treatments for bulimia nervosa Int J Clin Health Psychol 9 2009 51 71
9. D.A. Revicki, D. Stull, and M. Vernon Assessing the effect of darbepoetin alfa on patient-reported fatigue in chemotherapy-induced anemia in four randomized, placebo-controlled clinical trials Qual Life Res 21 2012 311 321
10. F. Li, T.E. Duncan, S.C. Duncan, and A. Acock Latent growth modeling of longitudinal data: a finite growth mixture modeling approach Struct Equ Modeling 8 2001 493 530
11. T. Jung, and K.A.S. Wickrama An introduction to latent class growth analysis and growth mixture modeling Soc Personal Psychol Compass 2 2008 302 317
12. G.H. Lubke, and B. Muthén Investigating population heterogeneity with factor mixture models Psychol Meth 10 2005 21 39
13. M. Muthén, C.H. Brown, and Jo KM Booil General growth mixture modeling for randomized preventive interventions Biostatistics 3 2002 459 475
14. Muthén B, Asparouhov T. Growth mixture modeling: analysis with non-Gaussian random effects. In: Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, eds., Longitudinal Data Analysis. Boca Raton, FL: Chapman & Hall/CRC Press:143-165
15. SOLVD Investigators Studies of Left Ventricular Dysfunction (SOLVD)-rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction Am J Cardiol 66 1990 315 322
16. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
17. W.J. Rogers, D.E. Johnstone, and S. Yusuf Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction J Am Coll Cardiol 23 1994 393 400
18. S.P. Clarke, N. Frasure-Smith, F. Lespérance, and M.G. Bourassa Psychosocial factors as predictors of functional status at 1 year in patients with left ventricular dysfunction Res Nurs Health 23 2000 290 300
19. D.E. Stull, L.A. Clough, and D. Van Dussen Self-report quality of life as a predictor of hospitalization for patients with left ventricular dysfunction: a life course approach Res Nurs Health 24 2001 460 469
20. T.G. Ganiats, D.K. Browner, and H.C. Dittrich Comparison of quality of well-being scale and NYHA functional status classification in patients with atrial fibrillation Am Heart J 135 1998 819 824
21. A.M. Jette, A.R. Davies, and P.D. Cleary The functional status questionnaire: reliability and validity when used in primary care J Gen Intern Med 1 1986 143 149
22. D.M. McNair, M. Lorr, and L.F. Droppleman Manual for the Profile of Mood States 1971 Educational Testing Service San Diego, CA
23. L.K. Muthén, and B.O. Muthén Mplus User's Guide 6th ed. 1998-2010 Muthén & Muthén Los Angeles, CA
24. L.T. Hu, and P.M. Bentler Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives Struct Equ Modeling 6 1999 1 55
25. R.B. Kline Principles and Practice of Structural Equation Modeling 3rd ed. 2010 Guilford Press New York
26. M. Browne, and R. Cudeck Alternative ways of assessing model fit K. Bollen, J. Long, Testing Structural Equation Models 1993 Sage Newbury Park, CA 136 162
27. D. Tofighi, and C.K. Enders Identifying the correct number of classes in growth mixture models G.R. Hancock, K.M. Samuelsen, Advances in Latent Variable Mixture Models 2008 Charlotte, NC: Information Age Publishing, Inc.
28. W.L. Leite, and L.A. Cooper Detecting social desirability bias using factor mixture models Multivariate Behav Res 45 2010 271 293
29. G. Lubke, and B.O. Muthen Performance of factor mixture models as a function of model size, covariate effects, and class-specific parameters Struct Equ Modeling 14 2007 26 47
30. StataCorp. Stata version 12.1. College Station, TX: StataCorp.
31. American Heart Association. http://www.heart.org/HEARTORG/Conditions/ HeartFailure/SymptomsDiagnosisofHeartFailure/Ejection-Fraction-Heart-Failure- Measurement-UCM-306339-Article.jsp. 2011. [Accessed June 17, 2011].
32. N. Stulz, M.E. Thase, and D.N. Klein Differential effects of treatments for chronic depression: a latent growth model reanalysis J Consult Clin Psychol 78 2010 409 419
33. K.L. Nylund, T. Asparouhov, and B. Muthén Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study Struct Equ Modeling 14 2007 535 569
34. J.L. Arbuckle Full information estimation in the presence of incomplete data G.A. Marcoulides, R.E. Schumacker, Advanced Structural Equation Modeling: Issues and Techniques 1996 Erlbaum Hillsdale, NJ
35. W. Wothke Longitudinal and multi-group modeling with missing data T.D. Little, K.U. Schnabel, J. Baumert, Modeling Longitudinal and Multilevel Data: Practical Issues, Applied Approaches, and Specific Examples 2000 Erlbaum Mahwah, NJ
36. J.L. Schafer, and J.W. Graham Missing data: Our view of the state of the art Psychol Meth 7 2002 147 177
37. C. Enders Missing not at random models for latent growth curve analyses Psychol Meth 16 2011 1 16
38. B.F. Kurland, L.L. Johnson, B.L. Egleston, and P.H. Diehr Longitudinal data with follow-up truncated by death: match the analysis method to research aims Stat Sci 24 2009 211
39. A.C. Leon, C.H. Mallinckrodt, and C. Chuang-Stein Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology Biol Psychiatry 59 2006 1001 1005
40. G. Molenberghs, H. Thijs, and I. Jansen Analyzing incomplete longitudinal clinical trial data Biostatistics 5 2004 445 464